Semaglutide

CAS

910463-68-2

Dose

5mg per vial

Formula

C₁₈₇H₂₉₁N₄₅O₅₉

4113.58 g/mol

Batch

PX-2026-0143

Purity

99.2%

Long-acting GLP-1 receptor agonist studied across the SUSTAIN, STEP, and SELECT clinical programs.

Per vial · CAD

CAD $79

Selected

5mg per vial

Choose dose

Order this vial

Lyophilized · ambient-stable · In stock

Batch PX-2026-0143 →

Research use only. Not for diagnostic, therapeutic, or human-consumption use.

Buying in volume? US and UK wholesale handled by direct contact — custom rates by monthly order volume.

Apply to the wholesale program

Production COA

Per batch

Verification

3rd party

Form

Lyophilized

Current batch

The chromatogram for this vial.

Full batch report

Batch PX-2026-0143 · HPLC trace

Semaglutide

Purity

99.2%

Produced

2026-04-04

Verified

2026-04-08

Signed by Independent third-party lab · 2026-04-08Hover the peaks to inspect retention times

Overview

About the compound.

Semaglutide is a 31-amino-acid GLP-1 receptor agonist with structural modifications conferring extended half-life. The compound has anchored the largest body of incretin research of the past decade — SUSTAIN (glycemic control), STEP (weight management), and SELECT (cardiovascular outcomes) — with parallel investigation in renal, hepatic, and neurological research at institutions in Copenhagen, Sapporo, and Shanghai.

Research contexts

GLP-1 receptor researchGlycemic control modelingCardiometabolic studies

Cited research